Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Yuan Li, Zhiyuan Xu, Shanming Ruan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 260

Showing 51-75 of 260 citing articles:

Deep Learning Approaches for lncRNA-Mediated Mechanisms: A Comprehensive Review of Recent Developments
Yoojoong Kim, Minhyeok Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10299-10299
Open Access | Times Cited: 12
Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer
Shao-Song Liu, Qin-Si Wan, Cong Lv, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer
Fei Yao, Danping Cao, Yanna Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
<p>Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686</p>
Yang Chai, Haitao Wu, Chuan-Dong Liang, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 8863-8872
Open Access | Times Cited: 36
Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
Wen-Kai Yu, Zhiyuan Xu, Yuan Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 34
Long noncoding RNA SNHG4: a novel target in human diseases
Qingfei Chu, Xinyu Gu, Qiuxian Zheng, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 29
The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives
Yifan Li, Lan Lu, Xu Wu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 11, pp. 2737-2755
Open Access | Times Cited: 28
PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway
Tao Liu, Junling Zhang, Hu Chen, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
Yuling Bin, Hongsai Hu, Feng Tian, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 20
Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
Chunguang Guo, Zaoqu Liu, Yin Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Gastric cancer cell-derived extracellular vesicles elevate E2F7 expression and activate the MAPK/ERK signaling to promote peritoneal metastasis through the delivery of SNHG12
Fangbin Zhang, Changqing Guo, Xinguang Cao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic
Peng Xia, Haitao Yuan, Ming Tian, et al.
Advanced Functional Materials (2022) Vol. 33, Iss. 7
Closed Access | Times Cited: 18
Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
Tianshi Wang, Dehai Wang, Yanan Sun, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 11
The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
Zidan Zhao, Tsz Kin Mak, Yuntao Shi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115337-115337
Open Access | Times Cited: 10
Efficacy and Safety of Traditional Chinese Medicines as a Complementary Therapy Combined With Chemotherapy in the Treatment of Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses
W. Xie, Yunsong Zhang, Jingyun Tang, et al.
Integrative Cancer Therapies (2024) Vol. 23
Open Access | Times Cited: 3
RETRACTED ARTICLE: LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b
Jianbo Guo, Li Yan, He Duan, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 30
Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications
Mingyao Huang, Xueqiang Peng, Liang Yang, et al.
Cancer Letters (2020) Vol. 501, pp. 234-246
Closed Access | Times Cited: 28
Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis
Zhibin Liao, Hongwei Zhang, Su Chen, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 26
Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy
Youhan Miao, Liping Mao, Xiaojuan Cai, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 25, pp. 3851-3862
Open Access | Times Cited: 23
RNF144A-AS1, a TGF-β1- and hypoxia-inducible gene that promotes tumor metastasis and proliferation via targeting the miR-30c-2-3p/LOX axis in gastric cancer
Zengliang Li, Liang Shi, Xiangwei Li, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy
Yufeng Xiao, Bo‐Sheng Li, Jingjing Liu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 16
LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
Hong Lin, Ruoxuan Ni, Dongdong Li, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 7, pp. 933-942
Open Access | Times Cited: 9
Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases
Raheleh Heydari, Sara Fayazzadeh, Shabnam Shahrokh, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 795-807
Closed Access | Times Cited: 9
PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1
Ya‐Wen Wang, Wenjie Zhu, Ran‐Ran Ma, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 9

Scroll to top